Product NDC: | 23359-018 |
Proprietary Name: | CENTUSSIN DHC |
Non Proprietary Name: | Dihydrocodeine Bitartrate, Brompheniramine Maleate, and Phenylephrine Hydrochloride |
Active Ingredient(s): | 4; 3; 7.5 mg/5mL; mg/5mL; mg/5mL & nbsp; Dihydrocodeine Bitartrate, Brompheniramine Maleate, and Phenylephrine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 23359-018 |
Labeler Name: | Centurion Labs, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20091124 |
Package NDC: | 23359-018-16 |
Package Description: | 473 mL in 1 BOTTLE (23359-018-16) |
NDC Code | 23359-018-16 |
Proprietary Name | CENTUSSIN DHC |
Package Description | 473 mL in 1 BOTTLE (23359-018-16) |
Product NDC | 23359-018 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dihydrocodeine Bitartrate, Brompheniramine Maleate, and Phenylephrine Hydrochloride |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20091124 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Centurion Labs, LLC |
Substance Name | BROMPHENIRAMINE MALEATE; DIHYDROCODEINE BITARTRATE; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 4; 3; 7.5 |
Strength Unit | mg/5mL; mg/5mL; mg/5mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |